Paper32129124
Tropomyosin receptor kinase inhibitors: an updated patent review for 2016-2019.
Bailey JJ and 5 others. Expert Opin Ther Pat, 2020. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Tropomyosin receptor kinase inhibitors: an updated patent review for 2016-2019. Papers, record 32129124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32129124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Design | Major topic |
| Neoplasms | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Animals | |
| Benzamides | |
| Drug Development | |
| Humans | |
| Indazoles | |
| Membrane Glycoproteins | |
| Patents as Topic | |
| Pyrazoles | |
| Pyrimidines | |
| Receptor, trkA | |
| Receptor, trkB | |
| Receptor, trkC |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40430383 | High-Risk Neuroblastoma Stage 4 (NBS4): Developing a Medicinal Chemistry Multi-Target Drug Approach. | Molecules | 2025 | https://conductscience.org/library/papers/40430383 | PubMed |
| 38785946 | Brain-Derived Neurotrophic Factor, Nociception, and Pain. | Biomolecules | 2024 | https://conductscience.org/library/papers/38785946 | PubMed |
| 38099919 | Chemistry and biology of specialized metabolites produced by Actinomadura. | Nat Prod Rep | 2024 | https://conductscience.org/library/papers/38099919 | PubMed |
| 36474768 | Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments. | Osteoarthr Cartil Open | 2021 | https://conductscience.org/library/papers/36474768 | PubMed |
| 36349142 | Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | https://conductscience.org/library/papers/36349142 | PubMed |
| 36326907 | Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative review. | Support Care Cancer | 2022 | https://conductscience.org/library/papers/36326907 | PubMed |
| 36289793 | Adenocarcinomas of the Lung and Neurotrophin System: A Review. | Biomedicines | 2022 | https://conductscience.org/library/papers/36289793 | PubMed |
| 36235036 | JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo. | Molecules | 2022 | https://conductscience.org/library/papers/36235036 | PubMed |
| 36173463 | BDNF and its signaling in cancer. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/36173463 | PubMed |
| 33643817 | Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/33643817 | PubMed |
| 33330081 | NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma. | Front Oncol | 2020 | https://conductscience.org/library/papers/33330081 | PubMed |
| 33200712 | Interplay of BDNF and GDNF in the Mature Spinal Somatosensory System and Its Potential Therapeutic Relevance. | Curr Neuropharmacol | 2021 | https://conductscience.org/library/papers/33200712 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NTRK1 | 4914 | PubTator's text mining | https://conductscience.org/library/genes/4914 | NCBI Gene |
| NTRK2 | 4915 | PubTator's text mining | https://conductscience.org/library/genes/4915 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32129124
GET https://conductscience.org/api/papers/v1/32129124/authors